Home › Funds › Lynx1 Capital Management LP › DTIL

Lynx1 Capital Management LP position in DTIL

PRECISION BIOSCIENCES INC · Health Care

Lynx1 Capital Management LP reported holding 2,758,215 shares of DTIL (PRECISION BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$17.3M, representing 2.67% of its reported portfolio and ranking #5 among its reported holdings. Lynx1 Capital Management LP has disclosed DTIL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)2.76M sh
Reported value held$17.27M
Portfolio Weight2.67%
First reportedQ4 2024
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's DTIL position evolved

Lynx1 Capital Management LP first disclosed a stake in DTIL in Q4 2024 at 766,051 shares (US$2.9M). The position peaked in Q3 2026 at 2,758,215 shares, worth US$17.3M. Across 8 filings, Lynx1 Capital Management LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,758,215 shares valued at US$17.3M — an increase of 1,807,749 shares quarter over quarter.. Notable position changes include a 35% increase in Q2 2025 (shares rose 31% over the following quarter), a 190% increase in Q3 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 766.05K $2.92M New
Q1 2025 766.05K $3.65M Hold
Q2 2025 1.04M $4.35M Add
Q3 2025 1.04M $5.76M Add
Q4 2025 993.91K $4.13M Reduce
Q1 2026 985.11K $5.42M Reduce
Q2 2026 950.47K $7.47M Reduce
Q3 2026 2.76M $17.27M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DTIL and 13F data

DTIL (PRECISION BIOSCIENCES INC) is a Health Care company. 47 other funds we track also report a position in DTIL — the largest reported positions include Bleichroeder LP (US$12.6M), Octagon Capital Advisors LP (US$2.7M), Empery Asset Management, LP (US$640K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DTIL

All DTIL fund holders →

FAQ

How long has Lynx1 Capital Management LP held DTIL?

Lynx1 Capital Management LP has disclosed DTIL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Lynx1 Capital Management LP's current position in DTIL?

As of Q3 2026, Lynx1 Capital Management LP holds 2.76M shares of DTIL (PRECISION BIOSCIENCES INC), valued at $17.27M, representing 2.67% of its reported portfolio and ranking #5.

Has Lynx1 Capital Management LP been buying or selling DTIL?

In the latest 13F filing (Q3 2026), Lynx1 Capital Management LP increased its position in DTIL. The position peaked in Q3 2026 at 2.76M shares.

Which other funds hold DTIL?

Other major institutional holders of DTIL include Bleichroeder LP, Octagon Capital Advisors LP, Empery Asset Management, LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.